Here’s How to Become a TFSA Millionaire This Decade

It is possible to become a TFSA millionaire in the 2020s by targeting stocks like VieMed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) and others right now.

Two hands holding champagne glasses toasting each other with Paris in the background

Image source: Getty Images.

When the Tax-Free Savings Account (TFSA) first launched in January 2009, it took some serious magic for investors to accumulate hundreds of thousands in their account, let alone a million. Today, becoming a TFSA millionaire is still an incredible achievement. However, it is no longer a goal that is reserved for the craftiest among us.

The cumulative contribution room in a TFSA stands at $69,500 in 2020. With the right moves, it is not out of the question that TFSA investors can turn this into seven figures over the course of a decade.

TFSA millionaire: Get in on healthcare stocks!

All investors should be taking a hard look at healthcare stocks to kick off this decade. The healthcare space enjoyed good growth in the 2010s. Leaps in medicine and an aging population in North America will continue to contribute to its performance. Below are two healthcare stocks that have provided explosive growth in recent months. These equities can put you on the fast track to becoming a TFSA millionaire.

Trillium Therapeutics (TSX:TRIL)(NASDAQ:TRIL) is a clinical-stage immuno-oncology company that develops therapies for the treatment of cancer. As I’d mentioned, our aging society has resulted in increased demand for cancer treatments. Cancer is the leading cause of death in Canada.

Allied Market Research recently forecast that the global cancer therapeutics market would reach $180 billion by 2026. This would represent a CAGR of 7.7% from 2019 to the end of the projection period. Shares of Trillium Therapeutics have climbed over 2,000% year over year. A $5,000 investment in Trillium a year ago would be worth roughly $107,000 as of close on June 17. In this instance, we’re already 10% of the way to becoming a TFSA millionaire.

VieMed Healthcare has not been quite as explosive as Trillium over the past year, but its shareholders also have reason to celebrate. Shares of VieMed have shot up 212% over the past three months as of close on June 17.

Technology continues to offer massive growth

As far as growth is concerned, technology will continue to give healthcare a run for its money. The TSX index has attracted critics for its lack of exposure to this electric sector. It may not offer the breadth of options we see south of the border, but there are still some fantastic stocks in the Great White North.

Shopify has been a huge success story since its IPO back in 2015. Shares of the e-commerce giant have climbed 114% in 2020 so far. Those who got in early have a lot to celebrate. However, the stock dropped below the $500 mark in the middle of March. That means TSFA investors could have more than doubled their money in this stock in a few short months. Shopify will undoubtedly be in the portfolios of some TFSA millionaires this decade.

Demographic shifts can propel your portfolio

We have discussed the importance of jumping into promising sectors like healthcare and technology. Paying attention to demographic trends can also pay off in the long term. Jamieson Wellness is one TSX stock that will benefit from an aging population. Baby boomers are some of the biggest consumers of supplements and natural health products. Shares of Jamieson, a manufacturer and distributor of these products, have climbed 76% year over year.

Investors who want to enter the TFSA millionaire club should pay close attention to companies like Jamieson.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify, Shopify, and Viemed Healthcare Inc.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »